Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Apr 12;11:3171–3185. doi: 10.2147/CMAR.S195424

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Gao et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

SLC5A1 was over-expressed in human pancreatic cancer and associated with poor prognosis. (A) Comparison of mRNA expressions of SLC5A1 and SLC5A2 between human pancreatic tumor tissues and normal tissue. Increased SLC5A1 and reduced SLC5A2 were observed in pancreatic tumor tissue as compared to normal tissue. (B) Kaplan-Meier plots of overall and disease-free survival in pancreatic cancer patients with low SLC5A1 and high SLC5A1. Patients with high SLC5A1 is associated with reduced overall survival. (C) Kaplan-Meier plots of overall and disease-free survival in pancreatic cancer patients with other SGLTs expression. There is no significant correlation in SGLTs expression with patients’ overall and disease-free survival rate. **P<0.01, ***P<0.0001.